Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Actelion brand of bosentan monohydrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,645Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus Gets USFDA Nod For Bosentan 32mg Oral Suspension
    Zydus Gets USFDA Nod For Bosentan 32mg Oral Suspension

    19 Feb 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/zydus-receives-final-approval-from-usfda-for-bosentan-tablets-for-oral-suspension-32-mg-19160

    INDPHARMAPOST
    19 Feb 2026
    Share Share
    Zydus Pharms’ Generics Bosentan Receives Approval in US
    Zydus Pharms’ Generics Bosentan Receives Approval in US

    17 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213981

    FDA
    17 Feb 2026
    Share Share
    Natco Debuts Bosentan Tablets in Us with 180-Day Exclusivity
    Natco Debuts Bosentan Tablets in Us with 180-Day Exclusivity

    21 Aug 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/natco-launches-bosentan-tablets-for-oral-suspension-in-us-with-180-day-exclusivity-17635

    INDPHARMAPOST
    21 Aug 2025
    Share Share
    Zydus Pharma`s Generics Bosentan Receives Approval in US
    Zydus Pharma`s Generics Bosentan Receives Approval in US

    10 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213981

    FDA
    10 Jun 2025
    Share Share
    Natco’s Receives First Generic Approval for Bosentan For in US
    Natco’s Receives First Generic Approval for Bosentan For in US

    05 Feb 2025

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=213154

    FDA
    05 Feb 2025
    Share Share
    Natco Pharma`s Generics Bosentan Receives Approval in US
    Natco Pharma`s Generics Bosentan Receives Approval in US

    05 Feb 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213154

    FDA
    05 Feb 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.